FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to paediatrics, allergology – immunology and microbiology, and concerns a method for selective decontamination of Staphylococcus aureus, Klebsiella pneumoniae in children. Bacteriophages are used in the presence of Micrococcaceae – Staphylococcus aureus and Enterobacteriaceae – Klebsiella pneumonieae families or their associations in the analysed material when analysing the microflora composition. Bacteriophages used are Bacteriophagum Staphylococcum in dose of 1–3 ml per os 2 times day and 1–3 ml per rectum before bedtime for no more than 8 days and Klebsiella polyvalent bacteriophage purified in dose of 1–3 ml per os 2 times day and 1–3 ml per rectum before bedtime for no more than 8 days. Introduction of bacteriophages is course. Frequency rate of the course is no more than 5 courses with an intercourse break of not more than 14 days.
EFFECT: invention provides preservation and acceleration of formation of a unique and individual composition of the intestinal microbiota of a child, formation of an immunoregulatory balance, as well as allows to achieve complete absence of clinical manifestations and aggravations of AD in catamnesis.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTION OF HEALTHCARE-ASSOCIATED INFECTIONS IN PATIENTS IN CHRONIC CRITICAL CONDITION | 2023 |
|
RU2818910C1 |
METHOD OF TREATING SYNOVITIS AND/OR SYNOVIAL CYSTS | 2013 |
|
RU2574004C2 |
METHOD OF TREATMENT OF INFECTION RELATED TO THE PROVISION OF MEDICAL ASSISTANCE CAUSED BY A CAUSATIVE AGENT OR PATHOGENS WITH MULTIPLE DRUG RESISTANCE | 2017 |
|
RU2664681C1 |
STRAIN OF Lactobacillus fermentum Z, USED FOR PRODUCTION OF PROBIOTIC CULTURED MILK FOODS | 2008 |
|
RU2412239C2 |
METHOD OF PREVENTING ATOPIC DERMATITIS IN INFANTS BY MODULATING MICROBIAL MECHANISM OF HISTAMINE FORMATION | 2017 |
|
RU2665173C1 |
METHOD FOR THE TREATMENT OF UNCOMPLICATED NECROTIZING ENTEROCOLITIS IN NEWBORNS WITH A BACTERIAL INFECTION AND IF INTRAUTERINE INFECTION IS SUSPECTED | 2021 |
|
RU2771856C1 |
METHOD FOR PREDICTION OF ATOPIC DERMATITIS DEVELOPMENT IN INFANTS | 2016 |
|
RU2635768C1 |
METHOD OF DIAGNOSING DYSBIOTIC DISORDERS IN BIOPSIES OF NASAL MUCOSA, PHARYNX IN INFANTS AND PRESCHOOL CHILDREN WITH CONSTANTLY RECURRENT ACUTE RESPIRATORY INFECTIONS | 2013 |
|
RU2576839C2 |
METHOD FOR THE TREATMENT AND PREVENTION OF RECURRENCE OF NOSOCOMIAL PNEUMONIA | 2021 |
|
RU2794585C2 |
IMMUNOBIOLOGICAL ANTIALLERGIC AGENT (VERSIONS) AND Lactobacillus acidophilus 100 "аш" PA STRAIN USED FOR PRODUCTION OF IMMUNOBIOLOGICAL ANTIALLERGIC AGENT | 2008 |
|
RU2431663C2 |
Authors
Dates
2024-04-23—Published
2023-07-26—Filed